Pfizer amps up push into obesity treatments with $4.9B deal for Metsera
By TOM MURPHY Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing field with a nearly $5 billion acquisition. Related Articles A jury will look at whether Amazon tricked customers … Continued